FdaApplication

ANDA 205070

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMAZONE
application_typeANDA
approval_date2018-06-29

Products (3)

ProductActive ingredientStrengthDosage form
OMEPRAZOLEOMEPRAZOLE10MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE40MGCAPSULE, DELAYED REL PELLETS;ORAL
OMEPRAZOLEOMEPRAZOLE20MGCAPSULE, DELAYED REL PELLETS;ORAL

3 products